Regardless of Diabetes Status, Tight Glucose Control Reduces Risk for Severe Disease in COVID-19
Hyperglycemic patients treated with insulin infusion to maintain tight glucose control were at lower risk for severe disease in COVID-19.
Topics
Osteoporosis Treatment and Risk for Osteonecrosis of Sites Other Than the Jaw
The use of bone-specific drugs, such as those for osteoporosis treatment, is linked to an increased risk for osteonecrosis of sites other than the jaw.
COVID-19 Outcomes in Critically Ill Patients in New York City
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
Weight in Adolescence Linked to Early-Onset Type 2 Diabetes
Obesity in adolescence significantly increases the risk for incidence of type 2 diabetes in early adulthood in both sexes.
FDA Approves Treatment for Heavy Menstrual Bleeding Due to Uterine Fibroids
The FDA has approved Oriahnn™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules; AbbVie) for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
National Lipid Association Statement on Genetic Testing in Dyslipidemia
A scientific statement from the National Lipid Association outlines the implications of genetic testing in patients with dyslipidemia.
Osilodrostat Now Available for Treatment of Patients With Cushing Disease
Isturisa is exclusively available through the R.A.R.E.™ Patient Support Program and distributed via AnovoRx specialty pharmacy.
Superpotent Lots of Hypothyroidism Treatment NP Thyroid Recalled
Testing revealed that the product may have up to 115% of the labeled amount of Liothyronine (T3) (acceptable range is 90.0-110.0%).
Bisphosphonate Drug Holiday Not Associated With Increased Fracture or Mortality Risk
Fracture and mortality risk are not significantly different between periods of ongoing bisphosphonate treatment and bisphosphonate holidays.
FDA: Unacceptable NDMA Levels Identified in Certain Metformin ER Products
Specifically, unacceptable levels of this potentially carcinogenic impurity have been identified in products manufactured by 5 different firms.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes
